Messenger ribonucleic acid (mRNA) (nucleoside modified)
Information about Messenger ribonucleic acid (mRNA) (nucleoside modified)
Messenger ribonucleic acid (mrna) (nucleoside modified) uses
Messenger ribonucleic acid (mRNA) (nucleoside modified) is used to prevent Coronavirus disease (COVID-19).
How messenger ribonucleic acid (mrna) (nucleoside modified) works
Messenger ribonucleic acid (mRNA) (nucleoside modified) contains the genetic material of the virus, called mRNA, in a lipid capsule. Once the vaccine is administered, this lipid capsule helps in carrying the genetic code of the virus into the host cells (cells of the person receiving the vaccine). The mRNA cannot multiply or cause the disease. But, the immune system treats it as a foreign particle and is signaled to create antibodies against this mRNA. This helps the immune system to develop strong antibodies that can neutralize the actual virus if the individual is ever exposed to it. This kind of approach is safe for the body, ensures maximum protection, and does not cause the disease.
Common side effects of messenger ribonucleic acid (mrna) (nucleoside modified)
Injection site reactions (pain, swelling, redness), Fatigue, Headache, Muscle pain, Joint pain, Chills, Nausea, Vomiting, Swelling of lymph nodes, Fever
Available Medicine for Messenger ribonucleic acid (mRNA) (nucleoside modified)
Expert advice for Messenger ribonucleic acid (mRNA) (nucleoside modified)
- Messenger ribonucleic acid (mRNA) (nucleoside modified) is a 2-dose vaccination regimen. The second dose is administered 28 days after the first dose.
- It is given in the muscle (intramuscularly) of the upper arm.
- You may be observed for 15-30 minutes to monitor any allergic reactions that may occur after administering Messenger ribonucleic acid (mRNA) (nucleoside modified).
- Getting vaccinated is voluntary. However, it is advisable to complete the vaccination schedule to restrict the spread of the virus.
- In addition to vaccination, observe other control measures such as social distancing, mask donning, and hand-washing.
- Messenger ribonucleic acid (mRNA) (nucleoside modified) is currently not meant to be administered in children as safety and efficacy are not yet established.
Frequently asked questions for Messenger ribonucleic acid (mRNA) (nucleoside modified)
Messenger ribonucleic acid (mRNA) (nucleoside modified)
Q. Are there any serious side effects of Messenger ribonucleic acid (mRNA) (nucleoside modified)?
Yes, there have been instances of severe allergic reactions (anaphylaxis) in people who received Messenger ribonucleic acid (mRNA) (nucleoside modified). It is therefore advised that those people who experience an immediate severe allergic reaction to the first dose, should not receive additional doses. Additionally, there have been cases of myocarditis (inflammation in the heart muscle) and pericarditis (inflammation in the outer lining of the heart) seen in people, after getting the second dose particularly. If you have any doubts, consult your doctor.
Q. Does Messenger ribonucleic acid (mRNA) (nucleoside modified) protect against the newer strains/mutated versions of the COVID-19 virus?
As per the currently available evidence, newer strains/mutated versions of COVID-19 do not alter the safety or effectiveness of Messenger ribonucleic acid (mRNA) (nucleoside modified). So, it can be said that they may be able to protect you against the newer strains of the virus. However, studies are still underway to get more data around this.
Q. Can Messenger ribonucleic acid (mRNA) (nucleoside modified) be given to children?
Messenger ribonucleic acid (mRNA) (nucleoside modified) has not been studied for safety and effectiveness in the children/pediatric population so far. As per the current guidelines, only people aged 18 years or older are advised to receive this vaccine. Therefore, it is advised not to give any COVID-19 vaccine to children till we have enough data available.